Brazil artificial intelligence (AI) in medical Imaging market size was valued at $38 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 36.4% from 2022 to 2030 and will reach $449 Mn. The market is segmented by AI technology, solution, modality, application, and end User. Due to developments in AI and machine learning algorithms that are enabling the creation of more precise and effective medical imaging software, the Brazil Artificial Intelligence (AI) in the Medical Imaging market will expand. Some of the key players in this market inclue, Vitta (BRA), Hi Technologies (BRA), Brain4care (BRA), TissueLabs (BRA), Ninsaúde (BRA), Docway (BRA), Medcloud (BRA), Fiplex, Epistemic, BoaConsulta, GE Healthcare, Philips Healthcare, Siemens Healthineers,, IBM Watson Health, NVIDIA Corporation, and others.
Market Executive Summary
Brazil artificial intelligence (AI) in medical Imaging market size was valued at $38 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 36.4% from 2022 to 2030 and will reach $449. According to data from the World Bank, Brazil's total health expenditure as a percentage of GDP was 8.1%. This is lower than the average for high-income countries, which was 10.6%. The Brazilian government is the largest contributor to health expenditure, followed by households and private insurance companies. There has been a focus on increasing investment in the healthcare sector in recent years, particularly in areas such as primary healthcare and medical technology.
The increasing demand for AI-based medical imaging solutions, the growing prevalence of chronic diseases, and the government's initiatives to promote the adoption of digital technologies in healthcare are some of the key drivers of the market in Brazil. Additionally, the rise of private investments and partnerships between local companies and MNCs in the field of AI in medical imaging is expected to further boost the market growth in the country.
AI is being used in radiology to assist with image interpretation, diagnosis, and treatment planning. It is being used to identify abnormalities, lesions, and tumors in X-rays, CT scans, MRI, and ultrasound images. It also analyze cardiac images and help with diagnosis of heart conditions. It can assist in identifying anomalies, assessing heart function, and detecting heart disease.
Moreover, in oncology to assist with cancer diagnosis and treatment planning. It can help in detecting tumors, analyzing images to determine the stage and severity of cancer, and identifying treatment options AI is being used. Additionally, neurology diagnosis and treatment of neurological conditions is also being done by AI technology in various parts of Brazil. It can help in analyzing brain images to identify tumors, aneurysms, and other abnormalities, and in predicting patient outcomes. The demand for AI in Medical Imaging is increasing across Brazil, as healthcare providers seek to improve the accuracy and efficiency of diagnosis and treatment planning. Hence, Brazil AI in medical imaging market will grow in coming years.
The influx of big data, the availability of investment for AI-based startups, the development in cross-industry alliances and collaborations, and expanding government measures to promote the use of AI-based technologies are all contributing to the rapid growth of AI in medical diagnostics. It is projected that issues like a lack of knowledgeable AI employees, hazy rules, and a reluctance among medical experts to adopt these solutions will hinder market progress.
Market Growth Drivers
Market restraints:
Key Players
2021: (CNPq) announced funding for a research project focused on developing AI algorithms for medical imaging analysis. The project will involve collaboration between researchers from several Brazilian universities and aims to improve the accuracy and efficiency of medical imaging diagnosis.
2021: A Brazilian start-up called Navega Therapeutics announced that it had developed an AI-based platform for analyzing brain scans to aid in the diagnosis of Alzheimer's disease. The platform uses advanced machine learning algorithms to identify patterns and markers in brain scans that are indicative of Alzheimer's disease, with the aim of improving early diagnosis and treatment.
2022: the Brazilian Health Ministry announced plans to invest in AI-based medical imaging technologies as part of a wider push to improve the country's healthcare system. The ministry stated that the use of AI in medical imaging could help to improve the accuracy and speed of diagnoses, as well as reduce costs and improve patient outcomes.
In 2019, the Brazilian government created a National Artificial Intelligence Strategy with the objective of promoting the use of AI in different sectors and defining guidelines for its development in the country. This strategy is expected to have an impact on the use of AI in medical imaging as well.
In addition, the Brazilian National Health Surveillance Agency (ANVISA) has been working on the regulation of medical devices that use AI technology. In 2021, ANVISA published a public consultation document proposing guidelines for the regulation of medical devices that use AI. These guidelines include requirements for data quality, transparency, and safety, among others.
1. Report Description of the Brazil Artificial Intelligence (AI) in Medical Imaging Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Brazil Artificial Intelligence (AI) in Medical Imaging Market Executive Summary
2.1 Brazil Artificial Intelligence (AI) in Medical Imaging Market – Market Overview
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of the Brazil Artificial Intelligence (AI) in Medical Imaging Market
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4. Brazil Artificial Intelligence (AI) in Medical Imaging Market Segmentation
4.1 By AI Technology
4.1.1 Deep Learning
4.1.2 Natural Language Processing (NLP)
4.1.3 Others
4.2 By Solution
4.2.1 Software Tools/ Platform
4.2.2 Services
4.2.3 Integration
4.2.4 Deployment
4.3 By Modality
4.3.1 CT scan
4.3.2 MRI
4.3.3 X-rays
4.3.4 Ultrasound Imaging
4.3.5 Nuclear Imaging
4.4 By Application
4.4.1 Digital Pathology
4.4.2 Oncology
4.4.3 Cardiovascular
4.4.4 Neurology
4.4.5 Lung (Respiratory System)
4.4.6 Breast (Mammography)
4.4.7 Liver (GI)
4.4.8 Oral Diagnostics
4.4.9 Other
4.5 By End Use
4.5.1 Hospital and Healthcare Providers
4.5.2 Patients
4.5.3 Pharmaceuticals and Biotechnology Companies
4.5.4 Healthcare Payers
4.5.5 Others
5. Brazil Artificial Intelligence (AI) in Medical Imaging Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.1 Overview
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.1 Overview
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.1 Overview
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.1 Overview
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.1 Overview
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in the Brazil
8.2 Regulatory Framework in the Brazil
8.3 Pricing & Reimbursement Scenario in Brazil Artificial Intelligence (AI) in Medical Imaging Market
9. Factors Driving Future Growth
9.1 New Trends and Development Brazil Artificial Intelligence (AI) in Medical Imaging Market
9.2 Future Opportunities
10. Strategic Recommendations
By AI Technology
By Solution
By Modality
When compared to CT scans, magnetic resonance imaging can produce pictures that are free of imperfections. Due to its efficiency in obtaining details and better-quality pictures of soft tissues, the MRI is frequently seen as a superior alternative to X-rays. Utilizing optical coherence tomography, three-dimensional interactions between the retina and membranes are made possible in order to control the vitreoretinal disease.
By Application
The market is dominated by the digital pathology segment, which can be linked to pathologists' rising productivity. A validation tool for image analytics is provided by digital pathology, helping pathologists process more slides in less time. This facilitates early illness identification and quicker therapy initiation. AI and digital pathology also assist doctors in making patient-centered decisions. The oncology market is also expected to grow in popularity as more individuals become aware of cancer and its increased incidence in the public. Personalized therapy is made possible by artificial intelligence algorithms that identify and comprehend the nature of malignancies. The second section focUses on AI-driven diagnostic imaging for the heart, brain, breast, and mouth.
By End Use
The market is dominated by the healthcare sector. This is becaUse hospitals are widely dispersed and accessible; hence, many patients like hospitals. The market for medical imaging AI is also anticipated to benefit from favorable reimbursement regulations. During the anticipated time, diagnostic centers are anticipated to grow in popularity. This may be attributable to elements including rising patient awareness and a desire for diagnostic procedures and tests, all of which are fueling the market's expansion. Due to its ease in providing high-quality medical facilities in remote places, particularly rural ones, the ambulatory category is expected to develop at a quicker CAGR throughout the projection period. The availability of qualified surgeons and a surplAustralia of the necessary equipment are contributing to the expansion of the hospital market. Government assistance in emerging nations is likely to boost hospital infrastructure and technologies throughout the forecast period, which is anticipated to caUse the hospital segment to see growth.
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?